
China robotaxis, Indian pharma among hedge fund top picks at Sohn Hong Kong
HONG KONG, June 2 (Reuters) - Hedge funds revealed their top investment ideas, ranging from Chinese self-driving taxis, an Indian drug retailer, to a Korean nuclear plant builder, at the annual Sohn investment conference in Hong Kong.
This year's picks are geographically more diverse compared to last year, suggesting that investors are actively seeking to spread their exposure to counter tariff uncertainties and market volatility.
San Francisco-based Flight Deck Capital sees upside potential in Chinese search engine giant Baidu (9888.HK), opens new tab, betting on its fast-growing auto-driving business.
Similar to Google's self-driving unit Waymo, Baidu's Apollo Go "is the only robo-taxi player in China that's not dependent on the capital markets to scale," Flight Deck founder and managing partner Jay Kahn said at the conference on Friday.
He expects China's taxi and ride-share industry to grow to around $237 billion by 2034, with Apollo taking a 15% market share. But that segment, together with Baidu's cloud business, is currently given zero valuation by the market, he said.
Notably, investor optimism on Chinese firms going overseas has not been derailed by the escalating U.S.-China trade war.
Hong Kong's Apeiron Capital pitched Chinese ride-hailing company DiDi Global , citing its improving margin at home and its quick market share building in Latin America. Meanwhile Triata Capital is upbeat on Chinese discount e-commerce player PDD (PDD.O), opens new tab, the owner of Temu.
"One statistic that a lot of people don't know is that their MAU right now is bigger than Amazon," Triata CIO Sean Ho said, referring to Temu's monthly active users.
Two investors set their sights on India's healthcare space.
Singapore's Arisaig Partners favors MedPlus Health Services (MEDP.NS), opens new tab, a leading pharmacy chain in India, as its private label products strengthen its low-price proposition, widening the gap with competitors.
"Inflation is lower, government is focusing on the middle class and consumer spending is coming off a low base. I simply believe this is the time when the consumer space in general will do better," Vatsal Mody, partner and head of India research at Arisaig Partners said in an interview ahead of the conference.
India-based hedge fund startup Panvira Management is bullish on Piramal Pharma (PIRM.NS), opens new tab, a contract development and manufacturing organisation (CDMO), expecting its growth to accelerate to high teens and to benefit from tax rate normalisation.
Other emerging hedge funds focused on opportunities in the security sector driven by geopolitical conflicts.
Jon Jhun, who manages MY.Alpha Management's new Korea-focused fund, chose Hyundai Engineering & Construction (000720.KS), opens new tab, which engages in nuclear plant engineering, procurement and construction (EPC).
"Korea dominates the ex-Russia, ex-China nuclear supply chain," he said.
Hong Kong's Frontline Global Management picked Spanish defence firm Indra Sistemas (IDR.MC), opens new tab, believing the firm will win more European contracts.
On the activist investor side, UK hedge fund Palliser Capital disclosed a 3% stake in Japan's Toyo Tire (5105.T), opens new tab at the event, urging the tire maker to boost shareholder returns by setting a "best-in-class" performance target and releasing its excess capital of about $900 million to shareholders.
Seth Fischer's Oasis Management is long Japanese entertainment complex chain Round One (4680.T), opens new tab, betting it will gain a re-rating as it ventures into the restaurant industry aiming to bring Michelin-quality Japanese food to the U.S.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Telegraph
an hour ago
- Telegraph
Fraud office investigates solar farm deals that sank council
The Serious Fraud Office (SFO) has launched an investigation into a company that took millions from an Essex council through alleged sham solar farm investments. Rockfire Investment Finance is accused of drawing Thurrock borough council into a fraudulent scheme that ultimately led to the local authority's bankruptcy. The council poured £655m of taxpayers' money into bond investments sold by Rockfire between 2016 and 2020. Rockfire promised it would provide returns of up to 6pc a year, underwritten by investments in solar farms across the UK. Thurrock borrowed more than £1bn from about 150 other local councils, in part to fund its investments in Rockfire's schemes. However, the deals went sour and the local authority was later declared effectively bankrupt in December 2022 after Rockfire failed to generate the promised returns. Thurrock was left with debts of £1.5bn at the time of its bankruptcy, while Rockfire is now in liquidation. No political party had overall control of the council when the investments were made. Thurrock has been Labour controlled since May 2024. The SFO has served a series of so-called Section 2 notices to financial institutions, requiring them to hand over information on Rockfire or face criminal sanctions themselves. Nick Ephgrave, the SFO's director, said: 'Today's action is a significant step in our investigation concerning this suspected criminality. 'We are grateful for the assistance of Essex Police, Thurrock council and others in the early stages of this inquiry.' Thurrock council described the investigation as a 'vital step toward securing justice and ensuring accountability on behalf of our communities'. Victoria Holloway, a Labour councillor since 2024, said: 'Since these catastrophic investments first came to light, this administration – standing firmly alongside our residents – has consistently and rightly called for a full investigation. 'Thurrock council will continue to fully support this investigation and will make sure the SFO has access to all the information it requires, as we have continued to do since these losses were uncovered. 'Alongside this, the council is vigorously pursuing civil claims against Rockfire and its owner, Liam Kavanagh, to recover public funds lost through these failed investments. Today's announcement strengthens our resolve to see this through.' The council has accused Mr Kavanagh of misappropriating funds to buy a yacht, private jet, and a country estate in Hampshire. Thurrock filed a High Court lawsuit against Mr Kavanagh in August last year. Mr Kavanagh, who is now believed to live in Dubai, denies the allegations. The scandal has proved costly for residents of Thurrock. Council tax rates were increased by 8pc last year and services for local residents have also been cut to secure the local authority's finances. While Thurrock contends it was the victim of a scam, a 2023 report by Essex County Council placed blame on the authority for ignoring 'multiple red flags' and downplaying criticism. The report said local politicians inside Thurrock council invested in Rockfire's schemes to 'avoid difficult decisions' without understanding the risks. Council leaders later 'attempted to conceal bad news and avoid public scrutiny' when their failures started coming to light, the report said.


The Independent
an hour ago
- The Independent
Investigation launched into suspected fraud against debt-ridden local council
The Serious Fraud Office has launched an investigation into failed investments in solar farms that left a local council £1.5 billion in debt. Investigators have issued so-called section 2 notices against banks and other financial institutions to demand documentation relevant to the case. Investments were made by Thurrock Council in Essex through Rockfire Investment Finance Plc and other companies operating within the Rockfire Group between 2016 and 2020. The local authority was offered returns of 3% to 6% on its multi-million pound investment. Rockfire went into liquidation, and Thurrock Council was effectively declared bankrupt in December 2022, with debts of £1.5 billion. It has since recouped £650 million of public money. Director of the Serious Fraud Office, Nick Ephgrave said: 'Today's action is a significant step in our investigation concerning this suspected criminality. 'We are grateful for the assistance of Essex Police, Thurrock Council and others in the early stages of this inquiry.' Victoria Holloway, Thurrock Council cabinet member for Place and the Environment, said: 'Since these catastrophic investments first came to light, this administration—standing firmly alongside our residents—has consistently and rightly called for a full investigation. 'We therefore strongly welcome today's announcement from the Serious Fraud Office (SFO). 'It represents a vital step toward securing justice and ensuring accountability on behalf of our communities. 'Thurrock Council will continue to fully support this investigation and will make sure the SFO has access to all the information it requires, as we have continued to do since these losses were uncovered. 'Alongside this, the council is vigorously pursuing civil claims against Rockfire and its owner, Liam Kavanagh, to recover public funds lost through these failed investments. 'Today's announcement strengthens our resolve to see this through.'


Sky News
an hour ago
- Sky News
Biotech king Evans lands $50m injection for Ellipses cancer drugs
Sir Christopher Evans, the renowned British biotech entrepreneur, is close to landing $50m (£37m) in funding for a developer of a new portfolio of cancer treatments. Sky News has learnt Sir Christopher, whose previous companies have included Biovex and Chiroscience, is in the advanced stages of securing the capital for Ellipses Pharma. City sources said Middle Eastern and Asian investors had provisionally agreed to provide the bulk of the new funding, which is expected to be committed at a valuation of about $800m (£592m). The capital injection is expected to be the last such fundraising before Sir Christopher seeks an initial public offering for Ellipses Pharma, with Hong Kong the likeliest listing venue. Ellipses' focus on oncology has previously drawn investment from prominent backers including Sir Tom Hunter's investment vehicle, West Coast Capital. The London-based company's board members include an executive from Mubadala, the Abu Dhabi sovereign wealth fund. In December, it announced the launch of a clinical trial programme in the UAE. "This tremendous commitment has led us to the point where our achievements can be brought to bear for the potential benefit of patients in UAE," Sir Christopher said at the time. "In many ways, we can now bring hope and an innovative therapy to people in the UAE and also enable healthcare professionals to collaborate and share research."